Based on the levels of IL-1β, TNF-α, and MIP-1α measured one month after the onset of the disease, Alonso-Domvínguez et al. managed to develop a highly accurate model for the early prediction of post-COVID-19 symptomatology [70,74]. The gene discussed is IL1B; the disease is COVID-19.